HAVCR1 and hereditary clear cell renal cell carcinoma: Nevertheless, predicting properties of KIM-1 as an urinary and serologic marker in some kinds of acute and chronic kidney injury, renal cell carcinoma, cardiovascular diseases may already be used in the current clinical practice.